Pyridine → HCID 20130091, compound
Reaction equation
[CH:1]1[CH:2]=[CH:3][C:4]2[N:9]=[C:8]([C:10]3[N:14]=[CH:13][S:12][CH:11]=3)[NH:7][C:5]=2[CH:6]=1.N1C=CC=CC=1.Cl[C:22]([O:24][CH2:25][Cl:26])=[O:23].[K+].[Br-]>C(Cl)(Cl)Cl>[Cl:26][CH2:25][O:24][C:22]([N:9]1[C:4]2[CH:3]=[CH:2][CH:1]=[CH:6][C:5]=2[N:7]=[C:8]1[C:10]1[N:14]=[CH:13][S:12][CH:11]=1)=[O:23]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a suspension of 15.0 g of thiabendazole in 300 ml of chloroform, 6 g of pyridine was added and the suspension cooled in an ice bath. Chloromethyl chloroformate (10.6 g) was added to the reaction mixture dropwise during 10 minutes with stirring. A clear solution was formed which was kept stirred at room temperature for 16 hours. After washing the chloroform solution with water, it was dried over Na2SO4 and evaporated to a light yellow solid weighing 20.4 g. It was crystallized from EtOAc-CHCl3. Obtained in two crops were 15.07 g of compound, m.p. 143°-144° NMR (CDCl3) δ5.9 (2H, s, OCH2Cl), 7.2-8.2 (5H, m, aromatic), 8.93 (1H, d, J=3 Hz, aromatic). IR (KBr) ν3095, 1780, 1460, 1374, 1340, 1194, 1140, 1078 cm-1.
Workup
- additionwas added
- temperaturethe suspension cooled in an ice bath
- customA clear solution was formed which
- stirringwas kept stirred at room temperature for 16 hours
- washAfter washing the chloroform solution with water, it
- dry with materialwas dried over Na2SO4
- customevaporated to a light yellow solid
- customIt was crystallized from EtOAc-CHCl3
- customObtained in two crops
Sources & evidence
- ORD record
- ord-f05a5127a7a84c60adf828539b30a6e2
- Source dataset
- uspto-grants-1988_07
- Patent number
- US04760057
Reaction notes
Loading…